LIST OF BINDING INTERFACES for query 'EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1' in category 'PROTEIN NAME'

(Click on the 'Details' column to view details on interfaces and similar patterns of amino acids)
Click on the 'View' column to view patterns on the structural viewer)

PDB	Ligand	Drug	Indication	Macromolecule/ Organism	Pfam	Binding_Interfaces (View)	Details
3zos	0LI	Ponatinib (DB08901)	Ponatinib is a kinase inhibitor used to treat patients with various types of chronic myeloid leukemia (CML).	EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1 (Homo sapiens)	PK_Tyr_Ser-Thr	3ZOS_A_0LIA1000  3ZOS_A_0LIA1004	Details
4bkj	STI	Imatinib (DB00619)	Imatinib is a tyrosine kinase inhibitor used to treat a number of leukemias, myelodysplastic/myeloproliferative disease, systemic mastocytosis, hypereosinophilic syndrome, dermatofibrosarcoma protuberans, and gastrointestinal stromal tumors.	EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1 (Homo sapiens)	PK_Tyr_Ser-Thr	4BKJ_A_STIA1000	Details
5bvw	1N1	Dasatinib (DB01254)	Dasatinib is a tyrosine kinase inhibitor used for the treatment of lymphoblastic or chronic myeloid leukemia with resistance or intolerance to prior therapy.	EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1 (Homo sapiens)	PK_Tyr_Ser-Thr	5BVW_A_1N1A1009	Details
PDB	Ligand	Drug	Indication	Macromolecule/ Organism	Pfam	Binding_Interfaces (View)	Details

[["3zos","0LI","Ponatinib (DB08901)","Homo sapiens","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","PK_Tyr_Ser-Thr"],["4bkj","STI","Imatinib (DB00619)","Homo sapiens","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","PK_Tyr_Ser-Thr"],["5bvw","1N1","Dasatinib (DB01254)","Homo sapiens","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","PK_Tyr_Ser-Thr"]]